Latest Articles

White Blood Cell Ratios Predict Melanoma Survival
BY WAYNE KUZNAR
The ratio of neutrophils to lymphocytes – two types of white blood cells – can give oncologists valuable information regarding a patient’s prognosis.
Bringing Cancer Care Closer to Home
BY KATIE KOSKO
Baylor Scott & White Health merger allows patients to access new treatments with ease.
Older Patients With Breast Cancer: Tell Your Doctor This
BY ELIZABETH GARDNER
It is important to consider quality of life and survival calculations when treating older patients with HER2-positive or triple-negative breast cancer (TNBC), according to a recent talk at the 2017 Lynn Sage Breast Cancer Symposium.
Drug Combination Improves Outcomes for Melanoma Subtype
BY WAYNE KUZNAR
In a recent phase 2 study, nearly half of patients who had resectable stage 3B/C BRAF V600-mutant melanoma achieved pathologic complete response (pCR) – meaning that no active cancer cells are present – with neoadjuvant combination therapy consisting of Tafinlar (dabrafenib) and Mekinist (trametinib).
Less May Be More in Prostate Cancer Treatment
BY ARIELA KATZ
A clinical trial will test whether partial prostate ablation matches radical prostatectomy in effectiveness — with fewer early side effects.
PSA Screening Rates Are No Longer Dropping
BY ARIELA KATZ
After a drop, the frequency of PSA screening for prostate cancer has stabilized.
Helping Children Cope With Your Cancer
BY JILL WEISKOPF BRUFSKY
An acute myeloid leukemia survivor shares her insight on raising 3 kids while fighting for her life. 
Sidelined by Cancer Side Effects? Here Are Resources to Help
BY BRIELLE URCIUOLI
From fatigue to chemo brain, Curetoday.com and CURE Magazine offer a variety of resources for people dealing with these effects.
Active Surveillance Is Best Bet for Low-Risk Prostate Cancer
BY ARIELA KATZ
Study: To prolong survival in early-stage prostate cancer that is low-risk, observe instead of operating.
x